Kymera Therapeutics (KYMR)
(Delayed Data from NSDQ)
$48.94 USD
-0.81 (-1.63%)
Updated Aug 27, 2024 04:00 PM ET
After-Market: $48.92 -0.02 (-0.04%) 5:20 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: -- |
9/2024 | $-0.83 | -1.58% |
Earnings Summary
For their last quarter, Kymera Therapeutics (KYMR) reported earnings of -$0.58 per share, beating the Zacks Consensus Estimate of $-0.69 per share. This reflects a positive earnings surprise of 15.94%. Look out for KYMR's next earnings release expected on November 07, 2024. For the next earning release, we expect the company to report earnings of -$0.83 per share, reflecting a year-over-year increase of 7.78%.
Earnings History
Price & Consensus
Zacks News for KYMR
Kymera (KYMR) Q2 Loss Narrower Than Expected, Pipeline in Focus
KYMR: What are Zacks experts saying now?
Zacks Private Portfolio Services